Stay updated on Comparing Antiviral Drugs in COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Comparing Antiviral Drugs in COVID-19 Clinical Trial page.

Latest updates to the Comparing Antiviral Drugs in COVID-19 Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check17 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check24 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check31 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check38 days agoChange DetectedThe page has been updated to reflect a new version, v2.16.0, while the previous version, v2.15.2, has been removed. Additionally, references to specific FDA-regulated drug and device products have been deleted.SummaryDifference1%
- Check67 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
Stay in the know with updates to Comparing Antiviral Drugs in COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Antiviral Drugs in COVID-19 Clinical Trial page.